InNexus Biotechnology Stock Forecast - Polynomial Regression

IXSBFDelisted Stock  USD 0.0001  0.00  0.00%   
The Polynomial Regression forecasted value of InNexus Biotechnology on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. InNexus Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of InNexus Biotechnology's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
InNexus Biotechnology polinomial regression implements a single variable polynomial regression model using the daily prices as the independent variable. The coefficients of the regression for InNexus Biotechnology as well as the accuracy indicators are determined from the period prices.

InNexus Biotechnology Polynomial Regression Price Forecast For the 26th of December

Given 90 days horizon, the Polynomial Regression forecasted value of InNexus Biotechnology on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict InNexus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that InNexus Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

InNexus Biotechnology Stock Forecast Pattern

Backtest InNexus BiotechnologyInNexus Biotechnology Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of InNexus Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent InNexus Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria34.379
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
A single variable polynomial regression model attempts to put a curve through the InNexus Biotechnology historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm

Predictive Modules for InNexus Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as InNexus Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00010.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.0000850.00
Details
Bollinger
Band Projection (param)
LowMiddleHigh
0.00010.00010.0001
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as InNexus Biotechnology. Your research has to be compared to or analyzed against InNexus Biotechnology's peers to derive any actionable benefits. When done correctly, InNexus Biotechnology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in InNexus Biotechnology.

InNexus Biotechnology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InNexus Biotechnology stock to make a market-neutral strategy. Peer analysis of InNexus Biotechnology could also be used in its relative valuation, which is a method of valuing InNexus Biotechnology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

InNexus Biotechnology Market Strength Events

Market strength indicators help investors to evaluate how InNexus Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading InNexus Biotechnology shares will generate the highest return on investment. By undertsting and applying InNexus Biotechnology stock market strength indicators, traders can identify InNexus Biotechnology entry and exit signals to maximize returns.

Currently Active Assets on Macroaxis

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in InNexus Stock

If you are still planning to invest in InNexus Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InNexus Biotechnology's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets